Aerie: Aerie Pharmaceuticals : Merger Agreement - Form 8-K
(marketscreener.com) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 ...https://www.marketscreener.com/quote/stock/AERIE-PHARMACEUTICALS-IN-14688906/news/Aerie-Pharmaceuticals-Merger-Agreement-Form-8-K-42229531/?utm_medium=RSS&utm_content=20221107
Read full article »
Aerie is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, ocular surface, and retinal diseases.
Read more